1. Home
  2. LIXT vs GLBS Comparison

LIXT vs GLBS Comparison

Compare LIXT & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • GLBS
  • Stock Information
  • Founded
  • LIXT 2005
  • GLBS 2006
  • Country
  • LIXT United States
  • GLBS Greece
  • Employees
  • LIXT N/A
  • GLBS N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • GLBS Marine Transportation
  • Sector
  • LIXT Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • LIXT Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • LIXT 20.5M
  • GLBS 21.9M
  • IPO Year
  • LIXT N/A
  • GLBS 2007
  • Fundamental
  • Price
  • LIXT $4.00
  • GLBS $1.25
  • Analyst Decision
  • LIXT
  • GLBS Strong Buy
  • Analyst Count
  • LIXT 0
  • GLBS 1
  • Target Price
  • LIXT N/A
  • GLBS $3.00
  • AVG Volume (30 Days)
  • LIXT 86.0K
  • GLBS 36.0K
  • Earning Date
  • LIXT 11-12-2025
  • GLBS 11-28-2025
  • Dividend Yield
  • LIXT N/A
  • GLBS N/A
  • EPS Growth
  • LIXT N/A
  • GLBS N/A
  • EPS
  • LIXT N/A
  • GLBS N/A
  • Revenue
  • LIXT N/A
  • GLBS $35,798,000.00
  • Revenue This Year
  • LIXT N/A
  • GLBS $16.13
  • Revenue Next Year
  • LIXT N/A
  • GLBS $20.15
  • P/E Ratio
  • LIXT N/A
  • GLBS N/A
  • Revenue Growth
  • LIXT N/A
  • GLBS 11.80
  • 52 Week Low
  • LIXT $0.64
  • GLBS $0.99
  • 52 Week High
  • LIXT $6.26
  • GLBS $1.64
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 41.53
  • GLBS 59.45
  • Support Level
  • LIXT $4.14
  • GLBS $1.15
  • Resistance Level
  • LIXT $4.49
  • GLBS $1.23
  • Average True Range (ATR)
  • LIXT 0.42
  • GLBS 0.04
  • MACD
  • LIXT 0.00
  • GLBS 0.00
  • Stochastic Oscillator
  • LIXT 34.03
  • GLBS 95.45

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: